Exam 5 Lecture 8 Flashcards

1
Q

candidiasis risk factors

A

broad spectrum antibiotics
PN
Neutropenia (ANC<500)
Receipt of immunosuppressive agents
Surgery
Intrabdominal perforation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

candida tx

A

Echinocandin
- micafungin (back up to flucanozole in not susceptible to flucanozole)
caspofungin
Anidulafungin

Once we know species, use flucanozole (albicans, tropicalis etc)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

candidiasis signs

A

Fever
Tachycardia
Tachypnea
Chills
Hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How long to treat candidemia

A

14 days after 1st negative blood culture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What things do we need before we narrow candida tx to oral therapy

A

-Need susceptibilities
- Patients needs to be clinically stable
- Negative repeat blood cultures
- Been in appropriate therapy for 48 hrs
- Chose the most narrow agent (ideally flucanozole)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How often to repear blood cultures for candidemia tx

A

48 hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

candidemia tx in neutropenic pts

A

Echino candins
- caspofungin
-Micafungin
-Anidulafungin

AMPHOTEREFCIN B 3-5 mg/kg/day

choose one

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is flucanozole preferred in

A

C albicans
C parapsilosis
C tropicalis
C lustainae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is voriconazole preferred in

A

Krusei

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

WHat are echinocandins preferred in?

A

C glabrata
C krusei
C lustainae
C auris

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Histoplasmosis clinical presentation

A

fevers, chills, fatigue, weightloss (big one), night sweats (big one), hepatosplenomegaly, cough, chest pain, dyspnea

CNS histoplasmosis sx- fever, headache, seizure, mental status changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Histo tx of acute pulmonary histo asymptomatic/mild immunocompetent host

A

No therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Mild/moderate disease with symptoms of histo tx in immunocompetent host

A

Itraconazole 200 mg TID x 3 days , 200 mg BID for 6-12 wks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mod- severe disease of histoplasmosis tx in immunocompetent patients

A

Lipid amphoterecin B 3-5 mg/kg/day x 1 week, then itraconazole 200 mg TID x 3 days followed by 200 mg BID for 12 wks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Histoplasmosis tx in immunocompromised hist

A

amphoterecin 3-5 mg/kg/day x 1-2 wks then itra 200 mg TID x 3 days followed by 200 mg BID for at least 12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

coccidioidomycosis tx of primary pulmonary disease

A

Most recover without therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

coccidiodomycosis treatment of primary respiratory infection when to treat

A

Large inocul, severe infection or concurrent risk factors (HIV, organ transplant, pregnancy, or high dose corticosteroids)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How to treat primary respiratory infection? duration

A

Flucanozole 400-800 mg PO/IV daily

3-6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

symptomatic chronic cavitary pneumonia treatment? duration

A

flucanozole 400-800 for 12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Diffuse pneumonia with bilateral or military infiltrate occidioides tx

A

Amphoterecin B treated for 12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Causative pathogens for cryptococcus? Where do we see each one

A

C neoformans- immunocompromised host

C gaattii- immunocompetent host

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What infection plays a major role in host defence against cryptococcus

A

Cell mediated immunity

23
Q

difference we see in cryptococcus patients with and without HIV

A

patients with HIV have less sx due to reduced immune system

24
Q

Most common presentation in cryptococcus

A

Meningitis

25
Q

How is cryptococcus diagnosed

A

Lumbar puncture

26
Q

cryptococcal meningitis tx of Non HIV infected, non transplant host

A

Induction- Amphoterecin + flucytosine 4 wks

Consolidation- flucanozole 400-800 mg PO daily x 8 wks

Maintenance- Flucanozole 200-400 PO daily 6-12 months

27
Q

Alternative cryptococcal meningitis tx in order

A

Ampho +flucytosine

Ampho + Flucanozole

Flucytosine + Flucanozole

High dose flucanozole

Amphoterecin alone

28
Q

Aspergillosis tx and duration

A

Voriconazole

for 6-12 wks

29
Q

Aspergillosis prophylaxis

A

Posaconazole

30
Q

Antibiotic characteristics that influence CSF/CNS penetration

A

Lipid solubility- Lipid soluble drugs penetrate
Ionixation- unionized drugs penetrate
Protein binding- Only free drug
Molecular weight- Low MW penetrate
Degree of meningeal inflamation- some drugs penetrate into CSF with inflammation

31
Q

Name drugs that need meningeal inflammation to achiever CSF concentrations

A

Penicillins
Some cephalosporins
Aztrenam
Meropenem
Collistin
Vancomycin

32
Q

Therapeutic antibiotics that do NOT achieve therapeutic concentrations with or without meningeal inflammation

A

Macrolides
Aminoglycosides
B lactamases
Clindamycin
Tetracyclines
Echinocandins

33
Q

How do bacteria gain access to CSF in meningitisq

A

Hematogenous ( through bloodstream)- common
Direct inoculatoon (skull fracture etc)

34
Q

cliunical signs and wx of meningitis

A

Brudzinski and kernig sign in adults
Bulging fontanel in children
Meningococcal rash

35
Q

diagnosis of bacterial meningitis

A

CSF 3 tubes via lumbar (microbiology, hematology and chemistry)

36
Q

When should antibiotics be given in bacterial meningitis

A

Should be given after LP and not before

37
Q

For bacterial meningitis, what do CSF labs look like

A

WBC>1000-5000
Differential >80% neutrophils
Proten >150
Glucose <50

38
Q

empiric antibiotics of neonates, infants, children and adults, older adults >50

A

Neonates- ampicillin + ceftriaxone/cefepime or ampicillin + Aminoglycoside

infants (1-23 months) and children- adults (2-50)- vanc + Ceftriaxone

> 50- Vanc + Ceftriaxone + Ampicillin

39
Q

What does ceftriaxone do in neonates

A

Causes billiary sludging

40
Q

if pt with bacterial meningitis has streptococcus spp and is sensitive to pen, intermediate/resistant to pen, cephalosporin resistant

A

Sensitive to pen- penicillin or amp
PCN intermediate/resistant- ceftriaxone
Cephalosporin resistant- vanc

41
Q

What to use for bacterial meningitis for reduction in neurologic sequale

A

Steroids before antibiotic

42
Q

Bacterial meningitis MSSA, MRSA tx

A

MSSA- nafcillin
MRSA- vanc

43
Q

bacterial meningitis with listeria monocytogenes tx

A

Ampicillin/gentamycin

44
Q

H influenzae bacterial meningitis tx

A

B lactamase negative- ampicillin
B lactamase positive- Ceftriaxone

45
Q

Bacterial meningitis tx with enterobacteriae (E coli etc)

A

Ceftriaxone
Cefepime
Neropenem

46
Q

Bacterial meningitis with N meningitidis tx

A

Pen or ceftriaxone

47
Q

Bacterial meningitis with S pneumoniae tx

A

Pen susceptoble- pen G or amp
Pen Resistant- vanc + Ceftriaxone

48
Q

When does dexamethasone decrease mortality and unfavorable outcome in adults with bacterial meningitis

A

only with S pneumo

49
Q

CSFinterpretation of fungal meningitis

A

WBC- 10-500
Differential- >50% lymphs
Protein- 40-150
Glucose- <30-70

50
Q

Treatment of fungal meningitis

A

induction- Ampho + Flucytosine for 2 wks
COnsolidation- Flucanozole 400-800 8 wks
Maintenance- flucanozole 200-400 mg 12 months (atleast 12 months AND CD4 > 200 cells/ml AND suppression of viral load on ART

51
Q

For patients living with HIV/AIDS, when should ART be initiated for cryptococcus patients

A

Not until 5 wks after initiation of tx for cryptococcal meningitis due to IRIS risk

52
Q

Viral meningitis often characterized by

A

Altered mental status

53
Q

CSF interpretation of viral meningitis

A

WBC- 5-300
Differential- 50% lymphs
protein- 30-150
Glucose- <40-70